Delivery Order SPE2DB24D8002-SPE2DB25FJMQG

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ORENCIA 125 MG/ML SYRINGEML. The contract has a ceiling value of $5,295.75 and is a Firm Fixed Price Delivery Order with a period of performance ending on February 5, 2025. This contract is not associated with a set-aside program. Dakota Drug, Inc. has also been awarded a single-award Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to the small disadvantaged business Dakota Drug, Inc. for the procurement of ORENCIA CLICKJECT 125 MG/MLML. The contract has a firm fixed price of $11,464.47 and a performance period through January 26, 2024. Dakota Drug, Inc. is a key supplier for the DLA's medical supply chain, holding a $999,999,999.00 Indefinite Delivery Contract under the ECAT Generation V Program to provide a wide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Orencia ClickJect 125 mg/mL pharmaceutical product. The firm-fixed-price contract has a ceiling value of $15,712.57 and a performance period extending through December 4, 2024. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $10,816.16, is for the delivery of Orencia ClickJect 125 mg/mL, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 22, 2024. Dakota Drug, Inc. is a key supplier for the DLA, holding a single-award Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $4,224.96 contract is for the delivery of ORENCIA 125 MG/ML SYRINGE/ML, a biologic drug used to treat autoimmune conditions. The contract has an ultimate completion date of May 13, 2024 and was awarded on May 10, 2024 without a set-aside designation. Dakota Drug,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is a Delivery Order valued at $5,032.29 for the delivery of ORENCIA CLICKJECT 125 MG/MLML, a pharmaceutical product. The contract has a firm fixed price pricing type and a period of performance extending to November 17, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2UQ0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Orencia 125 mg/ml syringes. The contract is a firm-fixed-price Delivery Order with a ceiling value of $10,460.93 and a completion date of January 23, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a $999,999,999.00 Indefinite Delivery...
This federal contract award, identified as SPE2DB24D8002|SPE2DB24FJMQJ, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,662.00 Firm Fixed Price Delivery Order is for the pharmaceutical product ORENCIA 125 MG/ML SYRINGEML. The award is not associated with a set-aside program and has an ultimate completion date of July 23, 2024. Dakota Drug, Inc. has an existing Indefinite Delivery Contract (IDC) with the DLA, contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, valued at $5,132.04, is for the provision of Orencia ClickJect 125 mg/ml, a pharmaceutical product. The award is not designated as a set-aside contract. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as...
This federal contract award, with ID SPE2DB24D8002|SPE2DB24FJMWX, was issued by the Defense Logistics Agency (DLA) to prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract, worth $3,886.59, is a firm fixed-price delivery order for the supply of ORENCIA 125 MG/ML SYRINGEML, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) with ID SPE2DB24D8001, valued at...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJMQG
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ORENCIA 125 MG/ML syringes. The $5,004.06 firm-fixed-price contract has an ultimate completion date of October 31, 2024.

Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, for the DLA Troop Support Medical's ECAT Generation V Program. This contract allows Dakota Drug, Inc. to efficiently deliver a comprehensive range of critical medical items to various defense healthcare facilities.

Generated 5/20/25, 2:15 PM